Abbott and Dexcom Seek New Trial in High-Stakes Glucose Monitor Patent Dispute

Just over two months after a jury in Wilmington delivered a mixed verdict in a patent lawsuit concerning glucose monitors, Abbott and Dexcom have both petitioned for a new trial. The legal battle centers on the proprietary technologies embedded in their respective glucose monitoring systems, reflecting the competitive nature of this high-stakes medical device sector. For further details on this ongoing case, visit the original article on Law360.